Abstract:Abstract [Background] The proto-oncogene Akt/PKB is activated in many human cancers including leukemias, and regulates the cell survival and apoptosis. Akt/PKB is activated by growth factors or the phosphatidylinositol-3,4,5-triphosphate via PI3K, phosphorylates many substrates for cell survival or proliferation. The tumor suppressor PTEN prevents Akt/PKB phosphorylation and activation. On the other hand, the PH domain leucine-rich repeat protein phosphatase (PHLPP) dephosphorylates Akt/PKB, induces apoptosis, and suppresses tumor growth. It has been reported that the expression levels of PHLPP are significantly reduced in several colon cancer and glioblastoma cell lines, and Akt/PKB phosphorylation is elevated. However, we found that PHLPP gene was overexpressed in MNCs derived from patients with acute leukemias and MDS. In this study, we have investigated the expression analysis and prognostic significance of the PHLPP gene in patients with acute leukemias and MDS. [Methods] The cells used in this study were human acute leukemia cell lines, HL60, U937, YRK2, CEM, and MOLT4 cells. Primary acute lymphoblastic leukemia (8 ALL (8 L2)), myelodysplastic syndromes (32 MDS (18 RAEB-I, 14 REAB-II)), and acute myeloblastic (25 AML (4 M1, 11 M2, 6 M4, 4 M5)) cells were obtained from the peripheral blood. Human normal mononuclear cells (MNCs) were isolated from peripheral blood (PB) of healthy volunteers after obtaining informed consents. For analysis of PHLPP mRNA, quantitative RT-PCR was performed in all cell lines and clinical samples. [Results] In all cell lines, the expressions of PHLPP mRNA were significantly increased more than normal MNCs. In HL60, U937, YRK2, CEM and MOLT4 cells transfected with the siRNA PHLPP, it is shown that the phosphorylation state of Akt was markedly increased compared to the untransfected cells. In the clinical samples obtained from patients with acute leukemias and myelodisplastic syndromes, the PHLPP gene was overexpressed in 7/8 (87.5%) of ALL, 14/25 (56%) of AML, and 26/32 (81.3%) of MDS. This higher expression was not associated to the counts of blasts of PB (P < 0.01). The relative folds of PHLPP gene expression were for AML: 3.02, MDS: 4.16, and ALL 3.62 compared to normal MNCs. Kaplan-Meier survival analysis revealed that lower PHLPP expression increases the probability of the longer overall and the progression free survival of the patients. Moreover, when CR status after chemotherapy, mean PHLPP expression levels were significantly reduced compared to unCR status after chemotherapy in MNCs derived from PB of patients with acute leukemias and myelodysplastic syndromes. [Conclusions] Our results suggest that the PHLPP gene was overexpressed in MNCs derived from the patients with acute leukemias and myelodysplastic syndromes and may possibly be characterized as a new marker of unfavorable prognosis for ALL, AML, and MDS.

PPM1D Knockdown Suppresses Cell Proliferation, Promotes Cell Apoptosis, and Activates p38 MAPK/p53 Signaling Pathway in Acute Myeloid Leukemia

Expression and Clinical Significance of Phospholipase D1 in De Novo Acute Myeloid Leukemia

A Novel Role for Malate Dehydrogenase 1 in Acute Myeloid Leukemia Progression

Role of Phosphatidylinositol 3-Kinase and Specific Protein Kinase B Isoforms in the Suppression of Apoptosis Mediated by the Abelson Protein-tyrosine Kinase

PNC¯27 Targeting Plasma Membrane HDM2: A Potentially Novel Therapeutic Approach for Acute Myeloid Leukemia (AML)

Knockdown of Protein Phosphatase 5 (PPP5C) Suppresses the Growth of Leukemic Cell Line U937.

[Effects of PIM1 Gene on Proliferation, Apoptosis and JAK2/STAT3 Signaling Pathway of Acute Myeloid Leukemia U937 Cells]

PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway

Simultaneous Inhibition of Pdk1/Akt and Fms-Like Tyrosine Kinase 3 Signaling by A Small-Molecule Kp372-1 Induces Mitochondrial Dysfunction and Apoptosis in Acute Myelogenous Leukemia

The roles of phosphorylation of signaling proteins in the prognosis of acute myeloid leukemia

Expression Analysis and Prognostic Significance of the PHLPP Gene in Acute Leukemias and Myelodysplastic Syndromes.

Apatinib Inhibits Proliferation and Induces Apoptosis of Acute Myeloid Leukemia Stem/Progenitor Like Cell Line(kg1α Cells) by Inhibition PI3K/AKT Signal Pathway

IL-33/IL1RL1 axis regulates cell survival through the p38 MAPK pathway in acute myeloid leukemia

Transcriptional Repression of CDKN2D by PML/RARα Contributes to the Altered Proliferation and Differentiation Block of Acute Promyelocytic Leukemia Cells

Long Non-Coding RNA RPPH1 Promotes the Proliferation, Invasion and Migration of Human Acute Myeloid Leukemia Cells Through Down-Regulating Mir-330-5p Expression.

Targeting PI3K, Mtor, ERK, and Bcl-2 Signaling Network Shows Superior Antileukemic Activity Against AML

TET1-mediated microRNA-188-5p promoter hydroxymethylation regulates PTEN/PI3K/AKT signaling pathway in acute myeloid leukemia cells

Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth

PML(NLS-) Inhibits Cell Apoptosis and Promotes Proliferation in HL-60 Cells

Knockdown of MAML1 Inhibits Proliferation and Induces Apoptosis of T‐cell Acute Lymphoblastic Leukemia Cells Through SP1‐dependent Inactivation of TRIM59

High PD‑L1 Expression Drives Glycolysis Via an Akt/mTOR/HIF‑1α Axis in Acute Myeloid Leukemia